We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$218B
AUM Growth
+$17B
Cap. Flow
+$6.68B
Cap. Flow %
3.06%
Top 10 Hldgs %
22.81%
Holding
10,425
New
1,217
Increased
3,775
Reduced
3,854
Closed
1,335

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$400M
2
C icon
Citigroup
C
+$395M
3
CELG
Celgene Corp
CELG
+$360M
4
AMZN icon
Amazon
AMZN
+$347M
5
RTX icon
RTX Corp
RTX
+$344M

Sector Composition

Rank Sector Weight
1 Technology 5.61%
2 Financials 4.93%
3 Healthcare 4%
4 Consumer Discretionary 3.82%
5 Industrials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNFI icon
6951
CALL
United Natural Foods
UNFI
$2.93B
$401K ﹤0.01%
44,700
-4,200
-9% -$48.3K
VIRT icon
6952
CALL
Virtu Financial
VIRT
$5.3B
$401K ﹤0.01%
18,400
+9,300
+102% +$219K
FRBK
6953
DELISTED
Republic First Bancorp Inc
FRBK
$401K ﹤0.01%
81,681
-718
-0.9% -$3.64K
PGNX
6954
CALL
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$401K ﹤0.01%
65,000
+7,100
+12% +$34.2K
CPRX
6955
DELISTED
Catalyst Pharmaceutical
CPRX
$400K ﹤0.01%
104,178
+88,859
+580% +$384K
GKOS icon
6956
PUT
Glaukos
GKOS
$10.9B
$400K ﹤0.01%
5,300
-7,400
-58% -$531K
GTN icon
6957
CALL
Gray Television
GTN
$538M
$400K ﹤0.01%
24,400
-65,100
-73% -$1.29M
MMI icon
6958
Marcus & Millichap
MMI
$1.2B
$400K ﹤0.01%
+12,979
New +$471K
UYM icon
6959
PUT
ProShares Ultra Materials
UYM
$40.3M
$400K ﹤0.01%
26,800
-1,200
-4% -$16.8K
HEES
6960
PUT
DELISTED
H&E Equipment Services
HEES
$399K ﹤0.01%
13,700
-5,000
-27% -$139K
PNR icon
6961
CALL
Pentair
PNR
$10.6B
$398K ﹤0.01%
10,700
-1,900
-15% -$72.1K
TOWN icon
6962
CALL
Towne Bank
TOWN
$3.5B
$398K ﹤0.01%
14,600
UEC icon
6963
Uranium Energy
UEC
$5.55B
$398K ﹤0.01%
290,450
-230,740
-44% -$318K
KFYP
6964
DELISTED
KraneShares CICC China Leaders 100 Index ETF
KFYP
$398K ﹤0.01%
+14,106
New +$391K
PJT icon
6965
CALL
PJT Partners
PJT
$4.46B
$397K ﹤0.01%
+9,800
New +$399K
VFF icon
6966
PUT
Village Farms International
VFF
$309M
$397K ﹤0.01%
34,700
+12,000
+53% +$152K
WDR
6967
CALL
DELISTED
Waddell & Reed Financial, Inc.
WDR
$397K ﹤0.01%
23,800
+6,700
+39% +$117K
ARQL
6968
PUT
DELISTED
Arqule Inc
ARQL
$397K ﹤0.01%
+36,100
New +$251K
GATX icon
6969
PUT
GATX Corp
GATX
$6.38B
$396K ﹤0.01%
5,000
-4,800
-49% -$365K
HXL icon
6970
PUT
Hexcel
HXL
$7.87B
$396K ﹤0.01%
4,900
-500
-9% -$36.3K
LEAD
6971
DELISTED
Siren DIVCON Leaders Dividend ETF
LEAD
$396K ﹤0.01%
11,362
-14,417
-56% -$496K
RS icon
6972
Reliance Steel & Aluminium
RS
$21.8B
$396K ﹤0.01%
+4,180
New +$374K
GHDX
6973
CALL
DELISTED
Genomic Health, Inc.
GHDX
$396K ﹤0.01%
6,800
-700
-9% -$41.5K
HASI icon
6974
CALL
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.41B
$395K ﹤0.01%
14,000
-1,900
-12% -$50.4K
SGU icon
6975
Star Group
SGU
$415M
$395K ﹤0.01%
+39,505
New +$384K

Similar funds

Ken Griffin's Q2 2019 Portfolio in Review

As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.

  • Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
  • Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
  • Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
  • Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
  • Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
  • Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
  • Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.

Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.